Lynapharma SRL
0.7 FTELynapharma reported total assets of 177,178 € at the end of the 2025 financial year (annual accounts filed with the NBB on 27 Oct 2026), with 0.7 full-time equivalent.
The score of Lynapharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +36 % Total assets +2 %
Accounts of the company itself (not consolidated).
The full file covers 9 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Lynapharma's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 14,113 € | ||||
| Equity | 146,487 € | ||||
| Cash | 71,551 € | ||||
| EBITDA | 24,481 € | ||||
| Total assets | 177,178 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 27 Oct 2026
- Year ended 31 Dec 2024filed on 29 Sep 2025
- Year ended 31 Dec 2023filed on 30 Sep 2024
- Year ended 31 Dec 2022filed on 30 Aug 2023
- Year ended 31 Dec 2021filed on 31 Aug 2022
Lynapharma's financial analysis
- Solvency82.7%sector median: 37.8%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Lynapharma
Lynapharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0666.517.583
- VAT number
- BE0666517583
- Peppol
- Registered · 0208:0666517583 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 21 Nov 2016
- Registered office
- 1060 Saint-Gilles
- Size
- Micro · 0.7 FTE
- Latest accounts
- 2025 · filed on 27 Oct 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Lynapharma (SRL) has been based in Saint-Gilles since 2016, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 14,113 € and equity of 146,487 €; its revenue is not published. With 0.7 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 82.7%, above the median of its sector (37.8%).
Companies similar to Lynapharma
Companies in the same business, of comparable size and area, outside its group.
- Pharmacie DES Pagodes Manufacture of basic pharmaceutical products Genappe · balance sheet 383,064 €
- ELA Services Retail sale of pharmaceutical products Uccle · balance sheet 920,384 €
- Apotheek Mees Zonhoven Retail sale of pharmaceutical products Zonhoven · balance sheet 447,814 €
- Smets Pharma Retail sale of pharmaceutical products Lier · balance sheet 452,862 €
- Boskant Retail sale of pharmaceutical products Merchtem · balance sheet 729,117 €
- Apoteek DE Smedt Retail sale of pharmaceutical products Asse · balance sheet 343,684 €
- Sirrah Retail sale of pharmaceutical products Tournai · balance sheet 84,897 €
- Humbeek Pharma Retail sale of pharmaceutical products Grimbergen · balance sheet 653,604 €
Frequently asked questions about Lynapharma
What is the revenue of Lynapharma?
Lynapharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Lynapharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0666517583 for Lynapharma, if the company is VAT-registered. Its company number (CBE) is 0666.517.583.
Where is the registered office of Lynapharma?
According to the CBE register, the registered office of Lynapharma is in 1060 Saint-Gilles.
What is the equity of Lynapharma?
At the close of the 2025 financial year, the equity of Lynapharma amounts to 146,487 €, a solvency of 82.7% of total assets.
How many people work at Lynapharma?
0.7 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Lynapharma?
The register lists 1 active mandates at Lynapharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Lynapharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →